Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
===========================================================================================================================================================================================

* Hussein A Tawbi
* Caroline Robert
* Jan C Brase
* Daniel Gusenleitner
* Eduard Gasal
* James Garrett
* Alexander Savchenko
* Güllü Görgün
* Keith T Flaherty
* Antoni Ribas
* Reinhard Dummer
* Dirk Schadendorf
* Georgina V Long
* Paul D Nathan
* Paolo A Ascierto